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Chagas’ disease (CD) still remains an important health
problem in Latin America. Cardiac involvement in CD is
associated wiht a high mortality and morbidity and one of
the major challenges is to identify high risk patients.There-
fore a risk score to predict death in CD was recently devel-
oped and validated by Rassi and colleagues. Considering
the hole of myocardial fibrosis(MF) on the pathogenesis of
CD we believe that CMR(cardiovascular magnetic reso-
nance) may become an important method to stratify
patients with CD. We sought to evaluate morphological
and functional characteristics, as well as the extent of MF
in patients with CD by CMR and to search the prognostic
value of MF detected by CMR, comparing these findings
with the recently developed score of mortality (Rassi’s
score).Thirty-nine seropositive patients for CD were stu-
died , divided in two main groups: group I, without appar-
ent cardiomyopathy consisted of 11 asymptomatic patients
without signs of cardiac involvement, and group II, with
apparent cardiomyopathy, consisted of 28 patients with
known heart involvement. We excluded patients with pre-
vious myocardial infarction, clinical or laboratory evidence
of ischemic heart disease, increased cholesterol levels,
diabetes, heart valve disease, pacemakers, Implantable def-
fibrilators and vascular brain clips. All patients underwent
CMR examination on 1,5T GE echo-speed, SYSTEM
(Wakeusha, Wiscosin). Short and long-axis of the heart
were obtained during breath-hold and triggered on eletro-
cardiogram pulse sequences. The first sequence was a
gradient-echo (steady-sate free procession) to assess left
ventricular (LV) and right ventricular (RV) morphology
and function. The second sequence was an inversion-
recovery prepared gradient-echo to obtain myocardial
delayed enhancement (MDE) ,10 to 20 minutes after
intravenous bolus of 0.2 mmol/Kg of gadolinium-based
contrast. Regarding the morphological and functional
analysis, significant differences were observed in both
groups (p< 0.001). Our data supports that there is an
inverse correlation between increasing Rassi’ss c o r e
numbers and LV ejection fraction (r = -0.78 p < 0.001).
Furthermore there was a strong correlation with the
extent of MF and the Rassi’s score (r = 0.76, p < 0.001);
and also with Rassi’s risk groups (low, intermediate and
high risk) (5±7.7; 19.8±17.3; e 38.1±17.7%, respectively
(p< 0,001, ANOVA). We concluded that CMR is an
important technique in the evaluation of patients with CD,
stressing morphological and functional differences in all
clinical presentations. The strong correlation with the Ras-
si`s score and the extent of myocardial fibrosis detected by
CMR, emphasizes its role in the prognostic stratification
of patients with CD.
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